1. Home
  2. DNLI vs IRDM Comparison

DNLI vs IRDM Comparison

Compare DNLI & IRDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • IRDM
  • Stock Information
  • Founded
  • DNLI 2013
  • IRDM 2000
  • Country
  • DNLI United States
  • IRDM United States
  • Employees
  • DNLI N/A
  • IRDM N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • IRDM Telecommunications Equipment
  • Sector
  • DNLI Health Care
  • IRDM Telecommunications
  • Exchange
  • DNLI Nasdaq
  • IRDM Nasdaq
  • Market Cap
  • DNLI 2.3B
  • IRDM 1.9B
  • IPO Year
  • DNLI 2017
  • IRDM N/A
  • Fundamental
  • Price
  • DNLI $15.21
  • IRDM $19.03
  • Analyst Decision
  • DNLI Strong Buy
  • IRDM Hold
  • Analyst Count
  • DNLI 15
  • IRDM 5
  • Target Price
  • DNLI $33.50
  • IRDM $27.60
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • IRDM 2.8M
  • Earning Date
  • DNLI 11-05-2025
  • IRDM 10-23-2025
  • Dividend Yield
  • DNLI N/A
  • IRDM 3.15%
  • EPS Growth
  • DNLI N/A
  • IRDM 42.40
  • EPS
  • DNLI N/A
  • IRDM 1.00
  • Revenue
  • DNLI N/A
  • IRDM $857,546,000.00
  • Revenue This Year
  • DNLI N/A
  • IRDM $7.49
  • Revenue Next Year
  • DNLI $95,463.19
  • IRDM $3.13
  • P/E Ratio
  • DNLI N/A
  • IRDM $18.96
  • Revenue Growth
  • DNLI N/A
  • IRDM 7.56
  • 52 Week Low
  • DNLI $10.57
  • IRDM $17.08
  • 52 Week High
  • DNLI $33.33
  • IRDM $35.85
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 54.76
  • IRDM 43.50
  • Support Level
  • DNLI $15.03
  • IRDM $18.12
  • Resistance Level
  • DNLI $16.51
  • IRDM $19.98
  • Average True Range (ATR)
  • DNLI 0.80
  • IRDM 0.74
  • MACD
  • DNLI 0.11
  • IRDM 0.35
  • Stochastic Oscillator
  • DNLI 61.42
  • IRDM 61.72

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About IRDM Iridium Communications Inc

Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.

Share on Social Networks: